Views & Analysis A collaborative approach to greater diversity in clinical tr... The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades.
Digital Company profile: Evidera Data disruption and applying ‘enabled intelligence’ to convert the promise shown in clinical trials into real-world success.
R&D Opening doors in pharmaceutical development Evidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase R&D efficiencies.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face